Filing Details
- Accession Number:
- 0001477932-21-003711
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-01 16:05:35
- Reporting Period:
- 2021-05-27
- Accepted Time:
- 2021-06-01 16:05:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1643301 | Cure Pharmaceutical Holding Corp. | CURR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1319880 | Jonathan Berlent | 1620 Beacon Place Oxnard CA 93033 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-27 | 10,000 | $0.69 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
